Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
2 citing papers in PubMed, 8 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
14 authors at 3 institutions in 1 country.
Maria S NazarenkoResearch Institute of Medical Genetics, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk 634050, Russia.ORCID 0000-0002-0673-4094
Aleksei A SleptcovResearch Institute of Medical Genetics, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk 634050, Russia.ORCID 0000-0003-3226-1750
Aleksei A ZarubinResearch Institute of Medical Genetics, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk 634050, Russia.ORCID 0000-0001-6568-6339
Ramil R SalakhovResearch Institute of Medical Genetics, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk 634050, Russia.ORCID 0000-0002-9789-9555
Alexander I ShevchenkoInstitute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences, Novosibirsk 630090, Russia.
Narek A TmoyanFederal State Budgetary Institution National Medical Research Center of Cardiology Named after Academician E.I. Chazov, Ministry of Health of Russian Federation, Moscow 121552, Russia.ORCID 0000-0002-3617-9343
Eugeny A ElisaphenkoInstitute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences, Novosibirsk 630090, Russia.
Ekaterina S ZubkovaFederal State Budgetary Institution National Medical Research Center of Cardiology Named after Academician E.I. Chazov, Ministry of Health of Russian Federation, Moscow 121552, Russia.ORCID 0000-0002-0512-3670
Nina V ZheltyshevaInstitute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences, Novosibirsk 630090, Russia.
Marat V EzhovFederal State Budgetary Institution National Medical Research Center of Cardiology Named after Academician E.I. Chazov, Ministry of Health of Russian Federation, Moscow 121552, Russia.ORCID 0000-0002-1518-6552
Valery V KukharchukFederal State Budgetary Institution National Medical Research Center of Cardiology Named after Academician E.I. Chazov, Ministry of Health of Russian Federation, Moscow 121552, Russia.
Yelena V ParfyonovaFederal State Budgetary Institution National Medical Research Center of Cardiology Named after Academician E.I. Chazov, Ministry of Health of Russian Federation, Moscow 121552, Russia.
Suren M ZakianInstitute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences, Novosibirsk 630090, Russia.
Irina S ZakharovaInstitute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences, Novosibirsk 630090, Russia.
Institute of Cytology and Genetics · RUNational Medical Research Center of Cardiology · RURussian Academy of Sciences · RU
Funding
Russian Science Foundation 21-15-00065
6 · The paper itself
Abstract
The
Indexed as
Hyperlipoproteinemia Type IINanoporesHumansMutationNucleotidesPhenotypeReceptors, LDLNucleotidesReceptors, LDLfamilial hypercholesterolemiahaplotypeLDLROxford Nanoporestructural variant
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.
Calling and Phasing of Single-Nucleotide and Structural Variants of the · full record | Socratic